$APRE ISIN: US03836J2015 Forum: Aktien User: 00000

Geht hier was? Ganz schön wenig Marktcap und natürlich hohes Risiko hmm

Geht hier was? Ganz schön wenig Marktcap und natürlich hohes Risiko hmm

Aprea Therapeutics (Nasdaq: APRE) announced a private placement to sell 2,623,023 shares (or pre-funded warrants) plus warrants to purchase up to 2,623,023 shares, priced at-the-market under Nasdaq rules. The combined effective offering price per share (or pre-funded warrant) with accompanying warrant is $1.165, producing estimated gross proceeds of approximately $3.1 million before placement agent fees and expenses. Warrants carry a $1.04 exercise price, are exercisable immediately, and expire on the five-year anniversary tied to registration/resale eligibility. The company said net proceeds are intended for general corporate purposes and R&D and are expected to extend cash runway into Q1 2027. The Offering is expected to close on or about December 10, 2025, with Maxim Group as sole placement agent.

Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051